Resveratrol protects the brain of obese mice from oxidative damage

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Rege, Shraddha D ^a   Kumar, Sruthi ^a   Wilson, David N ^b   Tamura, Leslie ^b   Geetha, Thangiah ^a   Mathews, Suresh T ^a   Huggins, Kevin W ^a   Broderick, Tom L ^b   Babu, Jeganathan Ramesh ^a,c  

^a AUBURN UNIVERSITY   (United States)

^b MIDWESTERN UNIVERSITY   (United States)

^c AUBURN UNIVERSITY AT MONTGOMERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-OXIDANT ACTIVITIES; BLOOD GLUCOSE LEVEL; GLUCOSE-6-PHOSPHATE DEHYDROGENASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; NEUROPROTECTIVE EFFECTS; NON-ENZYMATIC ANTIOXIDANTS; SUPER OXIDE DISMUTASE;

ANTHROPOMETRY; ANTIOXIDANTS; OXIDATION; OXYGEN; PEPTIDES; PEROXIDES; RESVERATROL;

MAMMALS;

ASCORBIC ACID; CATALASE; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; LIPID PEROXIDE; RESVERATROL; SUPEROXIDE DISMUTASE; TOCOPHEROL; ANTIOXIDANT; HYDROGEN PEROXIDE; MALONALDEHYDE; NEUROPROTECTIVE AGENT; STILBENE DERIVATIVE; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; BRAIN; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; LIPID PEROXIDATION; MALE; MOUSE; NEUROPROTECTION; NONHUMAN; OBESITY; OXIDATIVE STRESS; TISSUE INJURY; TREATMENT DURATION; ANIMAL; BLOOD; DRUG EFFECT; ENZYMOLOGY; METABOLISM; MOUSE MUTANT; PATHOLOGY; DRUG EFFECTS;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; BODY WEIGHT; BRAIN; HYDROGEN PEROXIDE; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; MICE; MICE, OBESE; NEUROPROTECTIVE AGENTS; OBESITY; OXIDATIVE STRESS; STILBENES; THINNESS;

EID: 84885639885     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/419092     Document Type: Article

References (50)

1. Freeman L. R., Zhang L., Nair A., Dasuri K., Francis J., Fernandez-Kim S. O., Obesity increases cerebrocortical reactive oxygen species and impairs brain function. Free Radical Biology and Medicine 2012 56 226 233
2. Naderali E. K., Ratcliffe S. H., Dale M. C., Obesity and alzheimer's disease: a link between body weight and cognitive function in old age. The American Journal of Alzheimer's Disease and other Dementias 2009 24 6 445 449 2-s2.0-70450255115 10.1177/1533317509348208
3. Luchsinger J. A., Mayeux R., Adiposity and Alzheimer's disease. Current Alzheimer Research 2007 4 2 127 134 2-s2.0-34147105943 10.2174/ 156720507780362100 (Pubitemid 46562392)
4. Balaban R. S., Nemoto S., Finkel T., Mitochondria, oxidants, and aging. Cell 2005 120 4 483 495 2-s2.0-13944278132 10.1016/j.cell.2005.02.001 (Pubitemid 40269763)
5. Kregel K. C., Zhang H. J., An integrated view of oxidative stress in aging: basic mechanisms, functional effects, and pathological considerations. The American Journal of Physiology 2007 292 1 R18 R36 2-s2.0-33846243745 10.1152/ajpregu.00327.2006 (Pubitemid 46091599)
6. Uttara B., Singh A. V., Zamboni P., Mahajan R. T., Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology 2009 7 1 65 74 2-s2.0-65949121134 10.2174/157015909787602823
7. Chen R.-S., Wu P.-L., Chiou R. Y.-Y., Peanut roots as a source of resveratrol. Journal of Agricultural and Food Chemistry 2002 50 6 1665 1667 2-s2.0-0037070370 10.1021/jf011134e (Pubitemid 34233243)
8. Soleas G. J., Diamandis E. P., Goldberg D. M., Wine as a biological fluid: history, production, and role in disease prevention. Journal of Clinical Laboratory Analysis 1997 11 287 313 (Pubitemid 27371787)
9. Ates O., Cayli S. R., Yucel N., Altinoz E., Kocak A., Durak M. A., Turkoz Y., Yologlu S., Central nervous system protection by resveratrol in streptozotocin-induced diabetic rats. Journal of Clinical Neuroscience 2007 14 3 256 260 2-s2.0-33846358150 10.1016/j.jocn.2005.12.010 (Pubitemid 46136016)
10. Venturini C. D., Merlo S., Souto A. A., Fernandes M. D. C., Gomez R., Rhoden C. R., Resveratrol and red wine function as antioxidants in the nervous system without cellular proliferative effects during experimental diabetes. Oxidative Medicine and Cellular Longevity 2010 3 6 434 441 2-s2.0-79960940619 10.4161/oxim.3.6.14741
11. Das S., Das D. K., Resveratrol: a therapeutic promise for cardiovascular diseases. Recent Patents on Cardiovascular Drug Discovery 2007 2 2 133 138 2-s2.0-34250756115 10.2174/157489007780832560 (Pubitemid 46957321)
12. Bertelli A. A. E., Ferrara F., Diana G., Fulgenzi A., Corsi M., Ponti W., Ferrero M. E., Bertelli A., Resveratrol, a natural stilbene in grapes and wine, enhances intraphagocytosis in human promonocytes: a co-factor in antiinflammatory and anticancer chemopreventive activity. International Journal of Tissue Reactions 1999 21 4 93 104 2-s2.0-0033512798 (Pubitemid 30186540)
13. Aggarwal B. B., Bhardwaj A., Aggarwal R. S., Seeram N. P., Shishodia S., Takada Y., Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Research 2004 24 5 2783 2840 2-s2.0-6944250259 (Pubitemid 39409568)
14. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 α Cell 2006 127 6 1109 1122 2-s2.0-33845399894 10.1016/j.cell.2006.11.013 (Pubitemid 44894520)
15. Zhang H., Zhang J., Ungvari Z., Zhang C., Resveratrol improves endothelial function: role of TNF α and vascular oxidative stress. Arteriosclerosis, Thrombosis, and Vascular Biology 2009 29 8 1164 1171 2-s2.0-68149150584 10.1161/ATVBAHA.109.187146
16. Zhang H., Morgan B., Potter B. J., Ma L., Dellsperger K. C., Ungvari Z., Zhang C., Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: in vivo demonstration with magnetic resonance imaging. The American Journal of Physiology 2010 299 4 H985 H994 2-s2.0-77958026411 10.1152/ajpheart.00489.2010
17. Sharma S., Misra C. S., Arumugam S., Roy S., Shah V., Davis J. A., Shirumalla R. K., Ray A., Antidiabetic activity of resveratrol, a known SIRT1 activator in a genetic model for type-2 diabetes. Phytotherapy Research 2011 25 1 67 73 2-s2.0-78650636700 10.1002/ptr.3221
18. Clark D., Tuor U. I., Thompson R., Institoris A., Kulynych A., Zhang X., Protection against recurrent stroke with resveratrol: endothelial function. Plos ONE 2012 7 10 e47792 10.1371/journal.pone.0047792
19. Walle T., Hsieh F., DeLegge M. H., Oatis J. E. Jr., Walle U. K., High absorption but very low bioavailability of oral resveratrol in humans. Drug Metabolism and Disposition 2004 32 12 1377 1382 2-s2.0-9444296057 10.1124/dmd.104.000885 (Pubitemid 39564557)
20. Hogberg J., Larson R. E., Kristoferson A., Orrenius S., NADPH dependent reductase solubilized from microsomes by peroxidation and its activity. Biochemical and Biophysical Research Communications 1974 56 3 836 842 2-s2.0-0015964456
21. Sinha A. K., Colorimetric assay of catalase. Analytical Biochemistry 1972 47 2 389 394 2-s2.0-0015353270
22. Rotruck J. T., Pope A. L., Ganther H. E., Swanson A. B., Hafeman D. G., Hoekstra W. G., Selenium: biochemical role as a component of glatathione peroxidase. Science 1973 179 4073 588 590 2-s2.0-0015918166
23. Staal G. E. J., Visser J., Veeger C., Purification and properties of glutathione reductase of human erythrocytes. Biochimica et Biophysica Acta 1969 185 1 39 48 2-s2.0-0014668096
24. Ells H. A., Kirkman H. N., A colorimetric method for assay of erythrocytic glucose-6-phosphate dehydrogenase. Proceedings of the Society for Experimental Biology and Medicine 1961 106 607 609 2-s2.0-0000241955
25. Omaye S. T., David Turnbull J., Sauberlich H. E., Selected methods for the determination of ascorbic acid in animal cells, tissues, and fluids. Methods in Enzymology 1979 62 3 11 2-s2.0-0018369625 10.1016/0076-6879(79)62181-X
26. Quaife M. L., Scrimshaw N. S., Lowry O. H., A micromethod for assay of total tocopherols in blood serum. The Journal of Biological Chemistry 1949 180 3 1229 1235 2-s2.0-0001575902
27. Öztürk O., Gümüşlü S., Changes in glucose-6-phosphate dehydrogenase, copper, zinc-superoxide dismutase and catalase activities, glutathione and its metabolizing enzymes, and lipid peroxidation in rat erythrocytes with age. Experimental Gerontology 2004 39 2 211 216 2-s2.0-0842305083 10.1016/j.exger.2003.10.015 (Pubitemid 38169412)
28. Bruce-Keller A. J., White C. L., Gupta S., Knight A. G., Pistell P. J., Ingram D. K., Morrison C. D., Keller J. N., NOX activity in brain aging: exacerbation by high fat diet. Free Radical Biology and Medicine 2010 49 1 22 30 2-s2.0-77953026364 10.1016/j.freeradbiomed.2010.03.006
29. Gemma C., Vila J., Bachstetter A., Bickford P. C., Riddle D. R., Oxidative stress and the aging brain: from theory to prevention. Brain Aging: Models, Methods, and Mechanisms 2007 Boca Raton, Fla, USA
30. Head E., Rofina J., Zicker S., Oxidative stress, aging, and central nervous system disease in the canine model of human brain aging. Veterinary Clinics of North America 2008 38 1 167 178 2-s2.0-38749153965 10.1016/j.cvsm.2007.10.002 (Pubitemid 351176589)
31. Mariani E., Polidori M. C., Cherubini A., Mecocci P., Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. Journal of Chromatography B 2005 827 1 65 75 2-s2.0-27644485874 10.1016/j.jchromb.2005.04. 023 (Pubitemid 41551598)
32. Liu R., Liu I. Y., Bi X., Thompson R. F., Doctrow S. R., Malfroy B., Baudry M., Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8526 8531 2-s2.0-0038491473 10.1073/pnas.1332809100 (Pubitemid 36842578)
33. Sun A. Y., Chen Y.-M., James-Kracke M., Wixom P., Cheng Y., Ethanol-induced cell death by lipid peroxidation in PC12 cells. Neurochemical Research 1997 22 10 1187 1192 2-s2.0-0030767237 10.1023/A:1021968526696 (Pubitemid 27440785)
34. Virgili M., Contestabile A., Partial neuroprotection of in vivo excitotoxic brain damage by chronic administration of the red wine antioxidant agent, trans-resveratrol in rats. Neuroscience Letters 2000 281 2-3 123 126 2-s2.0-0033993607 10.1016/S0304-3940(00)00820-X (Pubitemid 30125880)
35. Tadolini B., Juliano C., Piu L., Franconi F., Cabrini L., Resveratrol inhibition of lipid peroxidation. Free Radical Research 2000 33 1 105 114 2-s2.0-0034042402 (Pubitemid 30349988)
36. Huang T.-C., Lu K.-T., Wo Y.-Y. P., Wu Y.-J., Yang Y.-L., Resveratrol protects rats from A β -induced neurotoxicity by the reduction of iNOS expression and lipid peroxidation. PLoS ONE 2011 6 12 2-s2.0-84855283935 10.1371/journal.pone.0029102 e29102
37. Bertelli A. A. E., Giovannini L., Stradi R., Bertelli A., Tillement J.-P., Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4′5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. International Journal of Tissue Reactions 1996 18 2-3 67 71 2-s2.0-0030438633
38. Su H.-C., Hung L.-M., Chen J.-K., Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. The American Journal of Physiology 2006 290 6 E1339 E1346 2-s2.0-33744946526 10.1152/ajpendo.00487.2005 (Pubitemid 43847920)
39. Palsamy P., Subramanian S., Modulatory effects of resveratrol on attenuating the key enzymes activities of carbohydrate metabolism in streptozotocin-nicotinamide-induced diabetic rats. Chemico-Biological Interactions 2009 179 2-3 356 362 2-s2.0-62549115284 10.1016/j.cbi.2008.11.008
40. Keller J. N., Dimayuga E., Chen Q., Thorpe J., Gee J., Ding Q., Autophagy, proteasomes, lipofuscin, and oxidative stress in the aging brain. International Journal of Biochemistry and Cell Biology 2004 36 12 2376 2391 2-s2.0-4344618623 10.1016/j.biocel.2004.05.003 (Pubitemid 39119753)
41. Charradi K., Elkahoui S., Karkouch I., Limam F., Hassine F. B., Aouani E., Grape seed and skin extract prevents high-fat diet-induced brain lipotoxicity in rat. Neurochemical Research 2012 37 2004 2213
42. Baydas G., Reiter R. J., Yasar A., Tuzcu M., Akdemir I., Nedzvetskii V. S., Melatonin reduces glial reactivity in the hippocampus, cortex, and cerebellum of streptozotocin-induced diabetic rats. Free Radical Biology and Medicine 2003 35 7 797 804 2-s2.0-0142258702 10.1016/S0891-5849(03)00408-8 (Pubitemid 37329483)
43. Dincer Y., Akcay T., Alademir Z., Ilkova H., Effect of oxidative stress on glutathione pathway in red blood cells from patients with insulin-dependent diabetes mellitus. Metabolism 2002 51 10 1360 1362 2-s2.0-0036797684 10.1053/meta.2002.35192 (Pubitemid 35174160)
44. Tachi Y., Okuda Y., Bannai C., Bannai S., Shinohara M., Shimpuku H., Yamashita K., Ohura K., Hyperglycemia in diabetic rats reduces the glutathione content in the aortic tissue. Life Sciences 2001 69 9 1039 1047 2-s2.0-0035919681 10.1016/S0024-3205(01)01183-3 (Pubitemid 32701914)
45. Lykkesfeldt J., Moos T., Age-dependent change in Vitamin C status: a phenomenon of maturation rather than of ageing. Mechanisms of Ageing and Development 2005 126 8 892 898 2-s2.0-21344461701 10.1016/j.mad.2005.03.010 (Pubitemid 40909786)
46. Zhang P., Omaye S. T., Antioxidant and prooxidant roles for β -carotene, α -tocopherol and ascorbic acid in human lung cells. Toxicology in Vitro 2001 15 1 13 24 2-s2.0-0035106035 10.1016/S0887-2333(00)00054-0 (Pubitemid 32226370)
47. Traber M. G., Stevens J. F., Vitamins C and E: beneficial effects from a mechanistic perspective. Free Radical Biology and Medicine 2011 51 5 1000 1013 2-s2.0-80051668513 10.1016/j.freeradbiomed.2011.05.017
48. Mohar D. S., Malik S., The sirtuin system: the holy grail of resveratrol? Journal of Clinical and Experimental Cardiology 2012 3 11 10.4172/2155-9880. 1000216
49. Goldberg D. M., Yan J., Soleas G. J., Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clinical Biochemistry 2003 36 1 79 87 2-s2.0-0037248470 10.1016/S0009-9120(02)00397-1 (Pubitemid 36126394)
50. Jacob R. J., Fan X., Evans M. L., Dziura J., Sherwin R. S., Brain glucose levels are elevated in chronically hyperglycemic diabetic rats: no evidence for protective adaptation by the blood brain barrier. Metabolism 2002 51 12 1522 1524 2-s2.0-0036912284 10.1053/meta.2002.36347 (Pubitemid 36018823)